بدائل البحث:
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
greatest decrease » treatment decreased (توسيع البحث), greater increase (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
greatest decrease » treatment decreased (توسيع البحث), greater increase (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
-
1681
-
1682
Incidence number, ASIR under the age of 20 in 204 countries and territories in 2021.
منشور في 2025الموضوعات: -
1683
-
1684
DALYs number, ASDR under the age of 20 in 204 countries and territories in 2021.
منشور في 2025الموضوعات: -
1685
-
1686
-
1687
-
1688
-
1689
-
1690
-
1691
-
1692
-
1693
-
1694
Trends analysis in diabetes mellitus diagnosis according to relative handgrip strength.
منشور في 2024الموضوعات: -
1695
-
1696
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
1697
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
1698
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
1699
-
1700